Answers are grounded in this paper and cite their sources.
The 2016 AMR Review concluded that markets alone will not deliver the health technologies needed to address antimicrobial resistance, and recommended 'pull' funding mechanisms that align private incentives with social value.Although this recommendation has shaped policy for antibiotics, diagnostics have received comparatively little attention, despite being essential to both effective clinical care and antimicrobial stewardship.Without rapid, accurate diagnostics, clinicians prescribe under uncertainty, driving avoidable mortality and unnecessary antibiotic use, driving antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
O’Neill et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: